Related references
Note: Only part of the references are listed.Arginine- and Lysine-rich Peptides: Synthesis, Characterization and Antimicrobial Activity
Adriano Mollica et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2018)
Antifungal effects of phytocompounds on Candida species alone and in combination with fluconazole
Mengjiao Lu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Antifungal activity of acetone extracts from Punica granatum L., Quercus suber L. and Vicia faba L.
S. Akroum
JOURNAL DE MYCOLOGIE MEDICALE (2017)
Antifungal effects of Lavandula binaludensis and Cuminum cyminum essential oils against Candida albicans strains isolated from patients with recurrent vulvovaginal candidiasis
M. H. Minooeianhaghighi et al.
JOURNAL DE MYCOLOGIE MEDICALE (2017)
Correlation between Antimicrobial, Antioxidant Activity, and Polyphenols of Alkalized/Nonalkalized Cocoa Powders
Vanja Todorovic et al.
JOURNAL OF FOOD SCIENCE (2017)
Chemical composition and antifungal activity of Carica papaya Linn. seed essential oil against Candida spp.
X. He et al.
LETTERS IN APPLIED MICROBIOLOGY (2017)
Antimicrobial activity and phytochemical characterization of Carya illinoensis
Nathieli Bianchin Bottari et al.
MICROBIAL PATHOGENESIS (2017)
Antimicrobial activity of Buchenavia tetraphylla against Candida albicans strains isolated from vaginal secretions
Jose Robson Neves Cavalcanti Filho et al.
PHARMACEUTICAL BIOLOGY (2017)
Antifungal Drug Susceptibility of Candida Species Isolated from HIV-Positive Patients Recruited at a Public Hospital in Sao Luis, Maranhao, Brazil
Ana L. G. Tercas et al.
FRONTIERS IN MICROBIOLOGY (2017)
A Linear 19-Mer Plant Defensin-Derived Peptide Acts Synergistically with Caspofungin against Candida albicans Biofilms
Tanne L. Cools et al.
FRONTIERS IN MICROBIOLOGY (2017)
Phytochemical Characterization of Terminalia catappa Linn. Extracts and Their antifungal Activities against Candida spp
Analucia G. Tercas et al.
FRONTIERS IN MICROBIOLOGY (2017)
The Naturally Occurring Host Defense Peptide, LL-37, and Its Truncated Mimetics KE-18 and KR-12 Have Selected Biocidal and Antibiofilm Activities Against Candida albicans, Staphylococcus aureus, and Escherichia coli In vitro
Yu Luo et al.
FRONTIERS IN MICROBIOLOGY (2017)
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity
Ana C. O. Souza et al.
FRONTIERS IN MICROBIOLOGY (2017)
Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds
Malgorzata Bondaryk et al.
JOURNAL OF FUNGI (2017)
Review of flavonoids: A diverse group of natural compounds with anti-Candida albicans activity in vitro
Dalia Seleem et al.
ARCHIVES OF ORAL BIOLOGY (2017)
Structural, textural and morphological characteristics of tannins from Acacia mearnsii encapsulated using sol-gel methods: Applications as antimicrobial agents
Cristiane dos Santos et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
Voriconazole-associated visual disturbances and hallucinations
Gulsum Iclal Bayhan et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2016)
Phenolic compounds, antioxidant, and antibacterial properties of pomace extracts from four Virginia-grown grape varieties
Yixiang Xu et al.
FOOD SCIENCE & NUTRITION (2016)
Activity of crude extracts from Brazilian cerrado plants against clinically relevant Candida species
Amabel Fernandes Correia et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Factors related to outcome of bloodstream infections due to Candida parapsilosis complex
Francesco Barchiesi et al.
BMC INFECTIOUS DISEASES (2016)
Chemical Composition and Biological Activity of Centaurea baseri: New Species from Turkey
Yavuz Bulent Kose et al.
CHEMISTRY & BIODIVERSITY (2016)
Principles of a New Protocol for Prediction of Azole Resistance in Candida albicans Infections on the Basis of ERG11 Polymorphisms
Monika Caban et al.
CURRENT MICROBIOLOGY (2016)
Antifungal Activity of Condensed Tannins from Stryphnodendron adstringens: Effect on Candida tropicalis Growth and Adhesion Properties
Alexandre T. Morey et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2016)
Antifungal Agents Spectrum of Activity, Pharmacology, and Clinical Indications
Jeniel E. Nett et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
The Global Burden of Fungal Diseases
Snigdha Vallabhaneni et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Anti-Candida activity of geraniol involves disruption of cell membrane integrity and function
Y. Sharma et al.
JOURNAL DE MYCOLOGIE MEDICALE (2016)
Characterization and Physicochemical Properties of Condensed Tannins from Acacia catechu
Antoine Duval et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Chemical composition and biological activities of Artemisia judaica essential oil from southern desert of Jordan
M. S. Abu-Darwish et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Sarah Santos Goncalves et al.
MYCOSES (2016)
Novel strategies to fight Candida species infection
Maria Elisa Rodrigues et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2016)
Antifungal Activity and Action Mechanism of Histatin 5-Halocidin Hybrid Peptides against Candida ssp
Juhye Han et al.
PLOS ONE (2016)
Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11
Paola Morici et al.
PLOS ONE (2016)
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Dominique Sanglard
FRONTIERS IN MEDICINE (2016)
Identification and Antifungal susceptibility testing of Candida species: A Comparison of Vitek-2 system with conventional and molecular methods
Ravinder Kaur et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2016)
Essential Oil of Cymbopogon nardus (L.) Rendle: A Strategy to Combat Fungal Infections Caused by Candida Species
Luciani Gaspar De Toledo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Selected mechanisms of molecular resistance of Candida albicans to azole drugs
Karolina Gołąbek et al.
ACTA BIOCHIMICA POLONICA (2015)
Mechanisms of echinocandin antifungal drug resistance
David S. Perlin
ANTIMICROBIAL THERAPEUTICS REVIEWS (2015)
Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae
Ana Carolina R. Souza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study
Ricardo Dias de Castro et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
How to treat fungal infections in ICU patients
Dimitrios K. Matthaiou et al.
BMC INFECTIOUS DISEASES (2015)
Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy
Li Zhang et al.
BMC INFECTIOUS DISEASES (2015)
Azole antifungals: 35 years of invasive fungal infection management
David Allen et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Evaluation of bioactive properties and phenolic compounds in different extracts prepared from Salvia officinalis L.
Natalia Martins et al.
FOOD CHEMISTRY (2015)
Antifungal activity of Uncaria tomentosa (Willd.) DC against resistant non-albicans Candida isolates
Renata Cougo Moraes et al.
INDUSTRIAL CROPS AND PRODUCTS (2015)
Activity of phenolic compounds from plant origin against Candida species
Natalia Martins et al.
INDUSTRIAL CROPS AND PRODUCTS (2015)
Antifungal effect of Trachyspermum ammi against susceptible and fluconazole-resistant strains of Candida albicans
A. Sharifzadeh et al.
JOURNAL DE MYCOLOGIE MEDICALE (2015)
A new class of pegylated plasmonic liposomes: Synthesis and characterization
Rares Stiufiuc et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2015)
β-Defensin 1 Plays a Role in Acute Mucosal Defense against Candida albicans
Jeffrey Tomalka et al.
JOURNAL OF IMMUNOLOGY (2015)
Antifungal drug resistance among Candida species: mechanisms and clinical impact
Maurizio Sanguinetti et al.
MYCOSES (2015)
Antifungal activity of extracts from Cynomorium coccineum growing wild in Sardinia island (Italy)
Maria Jose Goncalves et al.
NATURAL PRODUCT RESEARCH (2015)
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans
Jinhui Cui et al.
VIRULENCE (2015)
In Vivo Anti-Candida Activity of Phenolic Extracts and Compounds: Future Perspectives Focusing on Effective Clinical Interventions
Natalia Martins et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Histatin 5 inhibits adhesion of C. albicans to Reconstructed Human Oral Epithelium
Eduardo B. Moffa et al.
FRONTIERS IN MICROBIOLOGY (2015)
Clinical Appearance of Oral Candida Infection and Therapeutic Strategies
Shankargouda Patil et al.
FRONTIERS IN MICROBIOLOGY (2015)
Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Stephanie A. Flowers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a US Surveillance System
Nina T. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae
Catarina Costa et al.
PLOS ONE (2015)
Mechanisms of Antifungal Drug Resistance
Leah E. Cowen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Comparative efficacy of herbal essences with amphotricin B and ketoconazole on Candida albicans in the in vitro condition
Shahin Gauanji et al.
INTEGRATIVE MEDICINE RESEARCH (2015)
Derivatives of the Mouse Cathelicidin-Related Antimicrobial Peptide (CRAMP) Inhibit Fungal and Bacterial Biofilm Formation
Katrijn De Brucker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vivo and In Vitro Acquisition of Resistance to Voriconazole by Candida krusei
Elisabete Ricardo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility
Biao Ren et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Some Strychnos spinosa (Loganiaceae) leaf extracts and fractions have good antimicrobial activities and low cytotoxicities
Adamu Imam Isa et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Evaluation of anticandidal and antioxidant activities of phenolic compounds from Pyrostegia venusta (Ker Gawl.) Miers
Ana Maria S. Pereira et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
In pursuit of the ideal antifungal agent for candida infections: high-throughput screening of small molecules
Sarah S. W. Wong et al.
DRUG DISCOVERY TODAY (2014)
Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
Daniele Maubon et al.
INTENSIVE CARE MEDICINE (2014)
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality
Matteo Bassetti et al.
INTENSIVE CARE MEDICINE (2014)
Utilising polyphenols for the clinical management of Candida albicans biofilms
Muhammad Shahzad et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Congestive heart failure related to antifungal therapy with itraconazole
Rene Vollenbroich et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Synergistic activity between Echinophora platyloba DC ethanolic extract and azole drugs against clinical isolates of Candida albicans from women suffering chronic recurrent vaginitis
M. Avijgan et al.
JOURNAL DE MYCOLOGIE MEDICALE (2014)
Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran
M. Razzaghi-Abyaneh et al.
JOURNAL DE MYCOLOGIE MEDICALE (2014)
Impact of New Antifungal Breakpoints on Antifungal Resistance in Candida Species
Annette W. Fothergill et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Phenylpropanoids of Plant Origin as Inhibitors of Biofilm Formation by Candida albicans
Jayant Shankar Raut et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Invasive Fungal Infections in the ICU: How to Approach, How to Treat
Elisabeth Paramythiotou et al.
MOLECULES (2014)
Green phytosynthesis of silver nanoparticles using aqueous extract of Manilkara zapota (L.) seeds and its inhibitory action against Candida species
S. V. Otari et al.
MATERIALS LETTERS (2014)
Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004-2008
Michael A. Pfaller et al.
PLOS ONE (2014)
Systematic Phenotyping of a Large-Scale Candida glabrata Deletion Collection Reveals Novel Antifungal Tolerance Genes
Tobias Schwarzmueller et al.
PLOS PATHOGENS (2014)
Efflux pump proteins in ant fungal resistance
Rajendra Prasad et al.
FRONTIERS IN PHARMACOLOGY (2014)
Epidemiology of Echinocandin Resistance in Candida
Nina T. Grossman et al.
CURRENT FUNGAL INFECTION REPORTS (2014)
Growth inhibitory response and ultrastructural modification of oral-associated candidal reference strains (ATCC) by Piper betle L. extract
Mohd-Al-Faisal Nordin et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2014)
Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China
Yu-Ye Li et al.
BMC INFECTIOUS DISEASES (2013)
Two unlike cousins: Candida albicans and C.glabrata infection strategies
Sascha Brunke et al.
CELLULAR MICROBIOLOGY (2013)
Finding the Missing 50% of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care
Cornelius J. Clancy et al.
CLINICAL INFECTIOUS DISEASES (2013)
Nanobiotechnology: An Efficient Approach to Drug Delivery of Unstable Biomolecules
A.C. Amaral et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2013)
Evaluation of Antimicrobial and Wound Healing Potential of Justicia flava and Lannea welwitschii
Christian Agyare et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
A Competitive Infection Model of Hematogenously Disseminated Candidiasis in Mice Redefines the Role of Candida albicans IRS4 in Pathogenesis
Suresh B. Raman et al.
INFECTION AND IMMUNITY (2013)
Opportunistic yeast infections: candidiasis, cryptococcosis, trichosporonosis and geotrichosis
Denisse Vazquez-Gonzalez et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2013)
Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China
Cen Jiang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options
J. C. O. Sardi et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Candida albicans and Non-C. albicans Candida Species: Comparison of Biofilm Production and Metabolic Activity in Biofilms, and Putative Virulence Properties of Isolates from Hospital Environments and Infections
A. V. Ferreira et al.
MYCOPATHOLOGIA (2013)
Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans
Ying-Lien Chen et al.
PLOS ONE (2013)
Trypanocide, cytotoxic, and anti-Candida activities of natural products: Hyptis martiusii Benth
Karla K. A. Santos et al.
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE (2013)
Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana
Francis Kwamin et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2013)
Candida albicans pathogenicity mechanisms
Francois L. Mayer et al.
VIRULENCE (2013)
Candida and Host Determinants of Susceptibility to Invasive Candidiasis
Michail S. Lionakis et al.
PLOS PATHOGENS (2013)
Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents
Claudia Spampinato et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Study of Candida albicans and its interactions with the host: A mini review
Pei-Wen Tsai et al.
BIOMEDICINE-TAIWAN (2013)
Antifungal Drug Resistance in Candida Species
Nasira Sheikh et al.
EUROPEAN JOURNAL OF GENERAL MEDICINE (2013)
Antimicrobial, antioxidant, and synergistic properties of two nutraceutical plants: Terminalia catappa L. and Colocasia esculenta L.
Sumitra Chanda et al.
TURKISH JOURNAL OF BIOLOGY (2013)
Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
Michael A. Pfaller
AMERICAN JOURNAL OF MEDICINE (2012)
Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats
Wei-Cheng Chen et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Polyphenols as antimicrobial agents
Maria Daglia
CURRENT OPINION IN BIOTECHNOLOGY (2012)
Alternative approaches to antifungal therapies
Tarun Mehra et al.
EXPERIMENTAL DERMATOLOGY (2012)
Candida albicans infection inhibits macrophage cell division and proliferation
Leanne E. Lewis et al.
FUNGAL GENETICS AND BIOLOGY (2012)
Invasive fungal infections in solid organ transplant recipients
Shmuel Shoham et al.
FUTURE MICROBIOLOGY (2012)
The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs
T. Noel
JOURNAL DE MYCOLOGIE MEDICALE (2012)
Pharmacological properties and protein binding capacity of phenolic extracts of some Venda medicinal plants used against cough and fever
R. B. Mulaudzi et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
The Antimicrobial Peptide hLF1-11 Drives Monocyte-Dendritic Cell Differentiation toward Dendritic Cells That Promote Antifungal Responses and Enhance Th17 Polarization
Anne M. van der Does et al.
JOURNAL OF INNATE IMMUNITY (2012)
In vitro antifungal activity of the flavonoid baicalein against Candida species
Rosana Serpa et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Antifungal Activity of Thymus vulgaris L. Essential Oil and Its Constituent Phytochemicals against Rhizopus oryzae: Interaction with Ergosterol
Kelly Samara de Lira Mota et al.
MOLECULES (2012)
Candida albicans-Epithelial Interactions: Dissecting the Roles of Active Penetration, Induced Endocytosis and Host Factors on the Infection Process
Betty Waechtler et al.
PLOS ONE (2012)
Retigeric Acid B Attenuates the Virulence of Candida albicans via Inhibiting Adenylyl Cyclase Activity Targeted by Enhanced Farnesol Production
Wenqiang Chang et al.
PLOS ONE (2012)
ORAL COLONIZATION BY YEASTS IN HIV-POSITIVE PATIENTS IN BRAZIL
Juliana C. Junqueira et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2012)
The effect of histatin 5, adsorbed on PMMA and hydroxyapatite, on Candida albicans colonization
D. Vukosavljevic et al.
YEAST (2012)
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
Ana C. Mesa-Arango et al.
Frontiers in Microbiology (2012)
Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
Olivier Lortholary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis
Vishnu Chaturvedi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Paradoxical Effect of Caspofungin against Candida Bloodstream Isolates Is Mediated by Multiple Pathways but Eliminated in Human Serum
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Antifungal effects of Ellagitannin isolated from leaves of Ocotea odorifera (Lauraceae)
Mirian Ueda Yamaguchi et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2011)
Oral candidosis - Clinical challenges of a biofilm disease
Riina Rautemaa et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2011)
Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations
Stuart K. Pitman et al.
EXPERT OPINION ON EMERGING DRUGS (2011)
Current perspectives on echinocandin class drugs
David S. Perlin
FUTURE MICROBIOLOGY (2011)
Echinocandins: Are They All The Same?
P. K. Mukherjee et al.
JOURNAL OF CHEMOTHERAPY (2011)
Candida albicans, a Major Human Fungal Pathogen
Joon Kim et al.
JOURNAL OF MICROBIOLOGY (2011)
Biologically Active Arborinane-Type Triterpenoids and Anthraquinones from Rubia yunnanensis
Jun-Ting Fan et al.
JOURNAL OF NATURAL PRODUCTS (2011)
In vitro antifungal activity of coumarin extracted from Loeselia mexicana Brand
Victor M. Navarro-Garcia et al.
MYCOSES (2011)
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1
Bjoern O. Schroeder et al.
NATURE (2011)
Antibacterial Activity of Thyme and Lavender Essential Oils
Monika Sienkiewicz et al.
MEDICINAL CHEMISTRY (2011)
Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease
Rebecca S. Shapiro et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2011)
Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle
Gajanan B. Zore et al.
PHYTOMEDICINE (2011)
Human Antimicrobial Peptide LL-37 Inhibits Adhesion of Candida albicans by Interacting with Yeast Cell-Wall Carbohydrates
Pei-Wen Tsai et al.
PLOS ONE (2011)
Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
Michael Tscherner et al.
PHARMACEUTICALS (2011)
A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14α-Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B
Claire M. Martel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009)
Michael A. Pfaller et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature
Florent Morio et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Candida spp. bloodstream infection: influence of antifungal treatment on outcome
M. Ortega et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
David A. Oxman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients
Emilia Siikala et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B A Review and Meta-Analysis
Amar Safdar et al.
MEDICINE (2010)
Antifungal Activity of the Essential Oil of Thymus x viciosoi against Candida, Cryptococcus, Aspergillus and Dermatophyte Species
Luis Andre Vale-Silva et al.
PLANTA MEDICA (2010)
The antifungal effect of six commercial extracts of Chilean propolis on Candida spp
Christian L Herrera et al.
Ciencia e Investigacion Agraria (2010)
Antifungal Activities of Human Beta-Defensins HBD-1 to HBD-3 and Their C-Terminal Analogs Phd1 to Phd3
Viswanatha Krishnakumari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Abc1p Is a Multidrug Efflux Transporter That Tips the Balance in Favor of Innate Azole Resistance in Candida krusei
Erwin Lamping et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Relative Contributions of the Candida albicans ABC Transporters Cdr1p and Cdr2p to Clinical Azole Resistance
Sarah Tsao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing
Huiping Wang et al.
BMC MICROBIOLOGY (2009)
An Essential Role for the NLRP3 Inflammasome in Host Defense against the Human Fungal Pathogen Candida albicans
Amy G. Hise et al.
CELL HOST & MICROBE (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization
A. C. D. Delgado et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted
Daniela Batovska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
New generation azole antifungals in clinical investigation
Corrado Girmenia
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Antifungal drug resistance mechanisms
Javier Peman et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation
Dominique Sanglard et al.
FEMS YEAST RESEARCH (2009)
Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans
Chia-Geun Chen et al.
FUNGAL GENETICS AND BIOLOGY (2009)
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis
Benoit P. Guery et al.
INTENSIVE CARE MEDICINE (2009)
Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009)
Ana Espinel-Ingroff
REVISTA IBEROAMERICANA DE MICOLOGIA (2009)
Essential Oils of Aromatic Plants with Antibacterial, Antifungal, Antiviral, and Cytotoxic Properties - an Overview
Juergen Reichling et al.
FORSCHENDE KOMPLEMENTARMEDIZIN (2009)
Structure-activity relationship of antibacterial chalcones
Hugo Pereira Avila et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
MFS transportome of the human pathogenic yeast Candida albicans
Manisha Gaur et al.
BMC GENOMICS (2008)
Resistance to antifungal agents: Mechanisms and clinical impact
Zeina A. Kanafani et al.
CLINICAL INFECTIOUS DISEASES (2008)
Candida biofilms:: Is adhesion sexy?
David R. Soll
CURRENT BIOLOGY (2008)
In vitro activity of terpenes against Candida biofilms
Stephanie Dalleau et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Epidemiology of candidemia in intensive care units
Emilio Bouza et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata
Riccardo Torelli et al.
MOLECULAR MICROBIOLOGY (2008)
Antimicrobial activity of three Baccharis species used in the traditional medicine of northern chile
Glauco Morales et al.
MOLECULES (2008)
Biofilm lifestyle of Candida: a mini review
C. J. Seneviratne et al.
ORAL DISEASES (2008)
Mechanisms of resistance to antifungal agents: Yeasts and filamentous fungi
Ana Espinel-Ingroff
REVISTA IBEROAMERICANA DE MICOLOGIA (2008)
New and emerging treatments for fungal infections
A. C. Pasqualotto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans
Joachim Morschhaeuser et al.
PLOS PATHOGENS (2007)
Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection
Antonella Lupetti et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Recent advances in antifungal chemotherapy
George Petrikkos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Resistance to echinocandin-class antifungal drugs
David S. Perlin
DRUG RESISTANCE UPDATES (2007)
Paradoxical effect of echinocandins across Candida species in vitro:: Evidence for echinocandin-specific and Candida species-related differences
Georgios Chamilos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
Ernst-Ruediger Kuse et al.
LANCET (2007)
Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults
L. Gualco et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Molecular mechanism of flucytosine resistance in Candida lusitaniae: Contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance
Nicolas Papon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
The DNA-binding domain of CaNdt80p is required to activate CDR1 involved in drug resistance in Candida albicans
Jang-Shiun Wang et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility
Santosh Katiyar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Aneuploidy and isochromosome formation in drug-resistant Candida albicans
Anna Selmecki et al.
SCIENCE (2006)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis
Jana Cernicka et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients
SY Li et al.
EPIDEMIOLOGY AND INFECTION (2006)
A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans
A Coste et al.
GENETICS (2006)
Currently used antimycotics:: Spectrum, mode of action and resistance occurrence
IEJA François et al.
CURRENT DRUG TARGETS (2005)
Fungal biofilms and antimycotics
J Chandra et al.
CURRENT DRUG TARGETS (2005)
Mechanisms of azole resistance in a clinical isolate of Candida tropicalis
P Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients
CY Looi et al.
FEMS MICROBIOLOGY LETTERS (2005)
In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus
C Serena et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Differential regulation of β-defensin expression in human skin by microbial stimuli
OE Sorensen et al.
JOURNAL OF IMMUNOLOGY (2005)
Efg1 involved in drug resistance by regulating the expression of ERG3 in Candida albicans
HJ Lo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The cathelicidins - Structure, function and evolution
L Tomasinsig et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2005)
Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance
M Sanguinetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Combination treatment of invasive fungal infections
PK Mukherjee et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Surface activity of thymol:: implications for an eventual pharmacological activity
ME Sánchez et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2004)
Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism
PM Silver et al.
EUKARYOTIC CELL (2004)
Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance
M Niimi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of candida albicans ABC transporters CDR1 and CDR2
AT Coste et al.
EUKARYOTIC CELL (2004)
CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1
CG Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The antimicrobial activity of lactoferrin: Current status and perspectives
N Orsi
BIOMETALS (2004)
A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains
H Kusch et al.
MOLECULAR GENETICS AND GENOMICS (2004)
Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis
JE Bennett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Activation of toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human β defensin-2
CJ Hertz et al.
JOURNAL OF IMMUNOLOGY (2003)
Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents
D Sanglard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke:: A clinical and experimental study
A Armengou et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
DP Kontoyiannis et al.
CANCER (2003)
In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts
F Mondello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Clinical pharmacology of antifungal compounds
AH Groll et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Antifungal drug resistance to azoles and polyenes
MM Canuto et al.
LANCET INFECTIOUS DISEASES (2002)
Expression of β-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells
LA Duits et al.
IMMUNOLOGY (2002)
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis
S Perea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles
S Perea et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Antifungal drug resistance of pathogenic fungi
DP Kontoyiannis et al.
LANCET (2002)
The solution structures of the human β-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus
DJ Schibli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Resistance of Candida species to antifungal agents:: molecular mechanisms and clinical consequences
D Sanglard et al.
LANCET INFECTIOUS DISEASES (2002)
Multicenter Brazilian study of oral Candida species isolated from Aids patients
PD Sant'Ana et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
The structure of human β-defensin-1 -: New insights into structural properties of β-defensins
DM Hoover et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Rationale for combination antifungal therapy
RE Lewis et al.
PHARMACOTHERAPY (2001)
Virulence factors of Candida albicans
RA Calderone et al.
TRENDS IN MICROBIOLOGY (2001)
Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata
D Sanglard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
The structure of human β-defensin-2 shows evidence of higher order oligomerization
DM Hoover et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Interactions between triazoles and amphotericin B against Cryptococcus neoformans
F Barchiesi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
A Vermes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Transcriptional analyses of antifungal drug resistance in Candida albicans
CN Lyons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor
S Wirsching et al.
JOURNAL OF BACTERIOLOGY (2000)
Share Paper
